Volume 51, Issue 3

Search all European Journal of Nuclear Medicine and Molecular Imaging articles

February 2024

36 articles in this issue

A Practical Guide for Pediatric Nuclear Medicine. Zvi Bar-Sever, Francesco Giammarile, Ora Israel, Helen Nadel (Editors). OPEN ACCESS
Luigi Mansi
Book Review 23 November 2023 Pages: 611 - 611
The 16^th Hangzhou International Molecular Imaging Conference (HIMIC 2023): the milestone of molecular imaging journey in China
Mei Tian
Hong Zhang
Editorial 05 December 2023 Pages: 612 - 614
Something still missing in molecular imaging: CXCR2 axis in prostate cancer
Luca Filippi
Laura Evangelista
Editorial 08 November 2023 Pages: 615 - 617
From pixels to predictions: the scrying power of molecular imaging
Gaia Ninatti
Cristiano Pini
Martina Sollini
Editorial 10 November 2023 Pages: 618 - 624
Development of novel peptide-based radiotracers for detecting PD-L1 expression and guiding cancer immunotherapy
Shiyu Zhu
Beibei Liang
Jianguo Lin
Original Article 25 October 2023 Pages: 625 - 640
STING-targeted PET tracer for early assessment of tumor immunogenicity in colorectal cancer after chemotherapy
Duo Xu
Xin Lu
Dan Li
Original Article 04 November 2023 Pages: 641 - 655
Development of a novel ¹⁸F-labeled small molecule probe for PET imaging of mesenchymal epithelial transition receptor expression
Lihong Bu
Xiaowei Ma
Zhen Cheng
Original Article 09 November 2023 Pages: 656 - 668
Mono- and multimeric PSMA-targeting small molecule-thorium-227 conjugates for optimized efficacy and biodistribution in preclinical models
Niels Böhnke
Bård Indrevoll
Sabine Zitzmann-Kolbe
Original Article Open access 26 October 2023 Pages: 669 - 680
Cardiac [^99mTc]Tc-hydroxydiphosphonate uptake on bone scintigraphy in patients with hereditary transthyretin amyloidosis: an early follow-up marker?
H. S. A. Tingen
A. Tubben
H. L. A. Nienhuis
Original Article Open access 16 October 2023 Pages: 681 - 690
Part of 1 collection:

Molecular imaging in cardiac amyloidosis
Treatment response assessment in transthyretin-related cardiac amyloidosis: an emerging clinical indication of bone-seeking radiopharmaceuticals?
Olivier Gheysens
Giorgio Treglia
Sharmila Dorbala
Editorial 19 December 2023 Pages: 691 - 694
Part of 1 collection:

Molecular imaging in cardiac amyloidosis
CT attenuation correction improves quantitative risk prediction by cardiac SPECT in obese patients
Attila Feher
Konrad Pieszko
Edward J. Miller
Original Article 04 November 2023 Pages: 695 - 706
Brain perfusion estimation by Tikhonov model-free deconvolution in a long axial field of view PET/CT scanner exploring five different PET tracers
Henrik Bo Wiberg Larsson
Ian Law
Ulrich Lindberg
Original Article Open access 16 October 2023 Pages: 707 - 720
Simultaneous high-resolution whole-brain MR spectroscopy and [¹⁸F]FDG PET for temporal lobe epilepsy
Hui Huang
Miao Zhang
Jie Luo
Original Article 12 October 2023 Pages: 721 - 733
Impact of simulated reduced injected dose on the assessment of amyloid PET scans
Peter Young
Fiona Heeman
on behalf of the AMYPAD consortium
Original Article Open access 28 October 2023 Pages: 734 - 748
Chemokine receptor–targeted PET/CT provides superior diagnostic performance in newly diagnosed marginal zone lymphoma patients: a head-to-head comparison with [¹⁸F]FDG
Aleksander Kosmala
Johannes Duell
Rudolf A. Werner
Original Article Open access 09 November 2023 Pages: 749 - 755
The evidence-based role of catecholaminergic PET tracers in Neuroblastoma. A systematic review and a head-to-head comparison with mIBG scintigraphy
Arnoldo Piccardo
Giorgio Treglia
Pietro Zucchetta
Review Article Open access 14 November 2023 Pages: 756 - 767
p53 stabilisation potentiates [¹⁷⁷Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
Hanna Berglund
Sara Lundsten Salomonsson
Marika Nestor
Original Article Open access 12 October 2023 Pages: 768 - 778
Exploring the association of glioma tumor residuals from incongruent [¹⁸F]FET PET/MR imaging with tumor proliferation using a multiparametric MRI radiomics nomogram
Xiaoran Li
Ye Cheng
Jie Lu
Original Article 21 October 2023 Pages: 779 - 796
[¹⁸F]FET PET/MR and machine learning in the evaluation of glioma
Leandra Piscopo
Emilia Zampella
Michele Klain
Editorial 13 November 2023 Pages: 797 - 799
PET/CT imaging with radiolabeled FAPI: new opportunities for diagnosis and treatment of thyroid cancer
Leandra Piscopo
Fabio Volpe
Editorial 27 September 2023 Pages: 800 - 802
Letter to the Editor: Postoperative thyroglobulin as a yard-stick for radioiodine therapy: decision tree analysis in a European multicenter series of 1317 patients with differentiated thyroid cancer
Fernanda Miyuki Sasaki
Aline Lopes Garcia Leal
Felipe Alves Mourato
Letter to the Editor 29 November 2023 Pages: 803 - 804
Therapeutic potential of [¹⁷⁷Lu]Lu-DOTAGA-FAPi dimers in metastatic breast cancer patients with limited treatment options: efficacy and safety assessment
Madhav P. Yadav
Sanjana Ballal
Chandrasekhar Bal
Original Article 07 November 2023 Pages: 805 - 819
The cycle effect quantified: reduced tumour uptake in subsequent cycles of [¹⁷⁷Lu]Lu-HA-DOTATATE during peptide receptor radionuclide therapy
H. Siebinga
J. J. M. A. Hendrikx
B. J. de Wit-van der Veen
Short Communication 16 October 2023 Pages: 820 - 827
The inferior performance of [⁶⁸Ga]Ga-FAPI-04 PET/CT as a diagnostic and theranostic biomarker in [¹⁷⁷Lu]Lu-DOTATATE refractory well-differentiated neuroendocrine tumors
Duygu Has Simsek
Yunus Guzel
Serkan Kuyumcu
Original Article 10 November 2023 Pages: 828 - 840
Changes in tumor-to-blood ratio as a prognostic marker for progression-free survival and overall survival in neuroendocrine tumor patients undergoing PRRT
Manuel Weber
Olof Pettersson
Anders Sundin
Original Article Open access 10 November 2023 Pages: 841 - 851
The role of [⁶⁸ Ga]Ga-FAPI-04 PET/CT in renal cell carcinoma: a preliminary study
Caner Civan
Serkan Kuyumcu
Yasemin Sanli
Original Article 07 October 2023 Pages: 852 - 861
FAPI PET/CT: a new kid on the block for RCC
Cristian Udovicich
Marlon Perera
Shankar Siva
Editorial 22 December 2023 Pages: 862 - 863
The prognostic role of next-generation imaging-driven upstaging in newly diagnosed prostate cancer patients
Matteo Bauckneht
Enrico Checcucci
Francesco Porpiglia
Short Communication 08 November 2023 Pages: 864 - 870
A phase 1 trial to determine the maximum tolerated dose and patient-specific dosimetry of [¹⁷⁷Lu]Lu-LNC1003 in patients with metastatic castration-resistant prostate cancer
Jie Zang
Guochang Wang
Jingjing Zhang
Original Article 21 October 2023 Pages: 871 - 882
Metastatic castration-resistant prostate cancer therapy: the quest for the perfect molecule
Davide Bianco
Carmela Nappi
Michele Klain
Editorial 21 November 2023 Pages: 883 - 884
Change in total lesion PSMA (TLP) during [¹⁷⁷Lu]Lu-PSMA-617 radioligand therapy predicts overall survival in patients with mCRPC: monocentric evaluation of a prospective registry
Caroline Burgard
Connor Hein
Florian Rosar
Original Article Open access 27 October 2023 Pages: 885 - 895
Assessing dynamic metabolic heterogeneity in prostate cancer patients via total-body [⁶⁸Ga]Ga-PSMA-11 PET/CT imaging: quantitative analysis of [⁶⁸Ga]Ga-PSMA-11 uptake in pathological lesions and normal organs
Ruohua Chen
Yee Ling Ng
Jianjun Liu
Original Article 27 October 2023 Pages: 896 - 906
Diagnostic accuracy of fully hybrid [⁶⁸Ga]Ga-PSMA-11 PET/MRI and [⁶⁸Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial
Samuele Ghezzo
Paola Mapelli
Maria Picchio
Original Article 28 October 2023 Pages: 907 - 918
A single-center, multi-factor, retrospective study to improve the diagnostic accuracy of primary prostate cancer using [⁶⁸Ga]Ga-PSMA-11 total-body PET/CT imaging
Jing Lv
Haojun Yu
Hongcheng Shi
Original Article 09 November 2023 Pages: 919 - 927
Pigmented villonodular synovitis detected by [⁶⁸Ga]Ga-FAPI-04 PET/CT
Chunmei Guo
Lingzhi Li
Zhanwen Huang
Image of the Month 27 October 2023 Pages: 928 - 929
Epithelioid granuloma mimicking lung cancer showed intense uptake on [¹⁸F]FAPI-74 PET
Tadashi Watabe
Ivan Ray David
Frederik L. Giesel
Image of the Month Open access 28 October 2023 Pages: 930 - 931

Volume 51, Issue 3

A Practical Guide for Pediatric Nuclear Medicine. Zvi Bar-Sever, Francesco Giammarile, Ora Israel, Helen Nadel (Editors). OPEN ACCESS

The 16^th Hangzhou International Molecular Imaging Conference (HIMIC 2023): the milestone of molecular imaging journey in China

Something still missing in molecular imaging: CXCR2 axis in prostate cancer

From pixels to predictions: the scrying power of molecular imaging

Development of novel peptide-based radiotracers for detecting PD-L1 expression and guiding cancer immunotherapy

STING-targeted PET tracer for early assessment of tumor immunogenicity in colorectal cancer after chemotherapy

Development of a novel ¹⁸F-labeled small molecule probe for PET imaging of mesenchymal epithelial transition receptor expression

Mono- and multimeric PSMA-targeting small molecule-thorium-227 conjugates for optimized efficacy and biodistribution in preclinical models

Cardiac [^99mTc]Tc-hydroxydiphosphonate uptake on bone scintigraphy in patients with hereditary transthyretin amyloidosis: an early follow-up marker?

Treatment response assessment in transthyretin-related cardiac amyloidosis: an emerging clinical indication of bone-seeking radiopharmaceuticals?

CT attenuation correction improves quantitative risk prediction by cardiac SPECT in obese patients

Brain perfusion estimation by Tikhonov model-free deconvolution in a long axial field of view PET/CT scanner exploring five different PET tracers

Simultaneous high-resolution whole-brain MR spectroscopy and [¹⁸F]FDG PET for temporal lobe epilepsy

Impact of simulated reduced injected dose on the assessment of amyloid PET scans

Chemokine receptor–targeted PET/CT provides superior diagnostic performance in newly diagnosed marginal zone lymphoma patients: a head-to-head comparison with [¹⁸F]FDG

The evidence-based role of catecholaminergic PET tracers in Neuroblastoma. A systematic review and a head-to-head comparison with mIBG scintigraphy

p53 stabilisation potentiates [¹⁷⁷Lu]Lu-DOTATATE treatment in neuroblastoma xenografts

Exploring the association of glioma tumor residuals from incongruent [¹⁸F]FET PET/MR imaging with tumor proliferation using a multiparametric MRI radiomics nomogram

[¹⁸F]FET PET/MR and machine learning in the evaluation of glioma

PET/CT imaging with radiolabeled FAPI: new opportunities for diagnosis and treatment of thyroid cancer

Letter to the Editor: Postoperative thyroglobulin as a yard-stick for radioiodine therapy: decision tree analysis in a European multicenter series of 1317 patients with differentiated thyroid cancer

Therapeutic potential of [¹⁷⁷Lu]Lu-DOTAGA-FAPi dimers in metastatic breast cancer patients with limited treatment options: efficacy and safety assessment

The cycle effect quantified: reduced tumour uptake in subsequent cycles of [¹⁷⁷Lu]Lu-HA-DOTATATE during peptide receptor radionuclide therapy

The inferior performance of [⁶⁸Ga]Ga-FAPI-04 PET/CT as a diagnostic and theranostic biomarker in [¹⁷⁷Lu]Lu-DOTATATE refractory well-differentiated neuroendocrine tumors

Changes in tumor-to-blood ratio as a prognostic marker for progression-free survival and overall survival in neuroendocrine tumor patients undergoing PRRT

The role of [⁶⁸ Ga]Ga-FAPI-04 PET/CT in renal cell carcinoma: a preliminary study

FAPI PET/CT: a new kid on the block for RCC

The prognostic role of next-generation imaging-driven upstaging in newly diagnosed prostate cancer patients

A phase 1 trial to determine the maximum tolerated dose and patient-specific dosimetry of [¹⁷⁷Lu]Lu-LNC1003 in patients with metastatic castration-resistant prostate cancer

Metastatic castration-resistant prostate cancer therapy: the quest for the perfect molecule

Change in total lesion PSMA (TLP) during [¹⁷⁷Lu]Lu-PSMA-617 radioligand therapy predicts overall survival in patients with mCRPC: monocentric evaluation of a prospective registry

Assessing dynamic metabolic heterogeneity in prostate cancer patients via total-body [⁶⁸Ga]Ga-PSMA-11 PET/CT imaging: quantitative analysis of [⁶⁸Ga]Ga-PSMA-11 uptake in pathological lesions and normal organs

Diagnostic accuracy of fully hybrid [⁶⁸Ga]Ga-PSMA-11 PET/MRI and [⁶⁸Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial

A single-center, multi-factor, retrospective study to improve the diagnostic accuracy of primary prostate cancer using [⁶⁸Ga]Ga-PSMA-11 total-body PET/CT imaging

Pigmented villonodular synovitis detected by [⁶⁸Ga]Ga-FAPI-04 PET/CT

Epithelioid granuloma mimicking lung cancer showed intense uptake on [¹⁸F]FAPI-74 PET

Navigation